Literature DB >> 8053890

Expression of the calcium-binding proteins MRP8 and MRP14 in monocytes is regulated by a calcium-induced suppressor mechanism.

J Roth1, M Goebeler, V Wrocklage, C van den Bos, C Sorg.   

Abstract

MRP8 and MRP14 are two calcium-binding proteins of the S-100 family the expression of which is restricted to distinct stages of monocytic differentiation. Heteromeric MRP8/MRP14 complexes have been shown to represent their biologically active forms. However, it is not as yet clear whether biochemical modification of complexes, or regulation on the transcriptional level, are responsible for the control of MRP8/MRP14 expression. Employing Western-blot analysis and metabolic labelling we have demonstrated that patterns and metabolism of MRP8/MRP14 complexes do not change during up- or down-regulation of MRP8/MRP14. By Northern-blot analysis it was shown that MRP8/MRP14 are regulated at the transcriptional level rather than by biochemical modification of the complexes. Elevation of intracellular calcium levels by A23187, as well as by thapsigargin, was found to lead to specific down-regulation of MRP8/MRP14 mRNA which is in contrast with data reported for inflammatory factors such as interleukin-1 or tumour necrosis factor alpha. Concomitant application of actinomycin D and calcium ionophore indicated that this suppressive effect is mediated by decreased synthesis rather than increased degradation of MRP8/MRP14 mRNA. Finally, we demonstrated that calcium-mediated down-regulation of MRP8-MRP14 can be antagonized by cycloheximide, suggesting that a calcium-induced repressor protein is responsible for suppression of MRP8-MRP14 at the transcriptional level. Our data indicate that the function of MRP8-MRP14 is restricted to events associated with early stages of myelomonocytic activation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8053890      PMCID: PMC1137038          DOI: 10.1042/bj3010655

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

1.  Monoclonal antibody 5.5 reacts with p8,14, a myeloid molecule associated with some vascular endothelium.

Authors:  N Hogg; C Allen; J Edgeworth
Journal:  Eur J Immunol       Date:  1989-06       Impact factor: 5.532

2.  Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin.

Authors:  M Steinbakk; C F Naess-Andresen; E Lingaas; I Dale; P Brandtzaeg; M K Fagerhol
Journal:  Lancet       Date:  1990-09-29       Impact factor: 79.321

3.  Leukocyte L1 protein and the cystic fibrosis antigen.

Authors:  K B Andersson; K Sletten; H B Berntzen; M K Fagerhol; I Dale; P Brandtzaeg; E Jellum
Journal:  Nature       Date:  1988-04-21       Impact factor: 49.962

Review 4.  The S100 protein family.

Authors:  D Kligman; D C Hilt
Journal:  Trends Biochem Sci       Date:  1988-11       Impact factor: 13.807

5.  Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues.

Authors:  G Zwadlo; J Brüggen; G Gerhards; R Schlegel; C Sorg
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

6.  Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase.

Authors:  O Thastrup; P J Cullen; B K Drøbak; M R Hanley; A P Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

7.  A protein complex expressed during terminal differentiation of monomyelocytic cells is an inhibitor of cell growth.

Authors:  S Murao; F Collart; E Huberman
Journal:  Cell Growth Differ       Date:  1990-10

8.  Cellular events associated with inflammatory angiogenesis in the mouse cornea.

Authors:  C Sunderkötter; W Beil; J Roth; C Sorg
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

9.  A protein containing the cystic fibrosis antigen is an inhibitor of protein kinases.

Authors:  S Murao; F R Collart; E Huberman
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

10.  Expression pattern of two related cystic fibrosis-associated calcium-binding proteins in normal and abnormal tissues.

Authors:  M M Wilkinson; A Busuttil; C Hayward; D J Brock; J R Dorin; V Van Heyningen
Journal:  J Cell Sci       Date:  1988-10       Impact factor: 5.285

View more
  7 in total

1.  Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases.

Authors:  Stephan Seeliger; Thomas Vogl; Ingo Hubert Engels; J Michael Schröder; Clemens Sorg; Cord Sunderkötter; Johannes Roth
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

2.  Quantitative proteomics reveals a role for epigenetic reprogramming during human monocyte differentiation.

Authors:  Dequina Nicholas; Hui Tang; Qiongyi Zhang; Jai Rudra; Feng Xu; William Langridge; Kangling Zhang
Journal:  Mol Cell Proteomics       Date:  2014-10-14       Impact factor: 5.911

3.  Importance of combined treatment with IL-10 and IL-4, but not IL-13, for inhibition of monocyte release of the Ca(2+)-binding protein MRP8/14.

Authors:  N Lügering; T Kucharzik; A Lügering; G Winde; C Sorg; W Domschke; R Stoll
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

Review 4.  Functional and clinical aspects of the myelomonocyte protein calprotectin.

Authors:  B Johne; M K Fagerhol; T Lyberg; H Prydz; P Brandtzaeg; C F Naess-Andresen; I Dale
Journal:  Mol Pathol       Date:  1997-06

5.  Calcium-induced noncovalently linked tetramers of MRP8 and MRP14 detected by ultraviolet matrix-assisted laser desorption/ionization mass spectrometry.

Authors:  T Vogl; J Roth; C Sorg; F Hillenkamp; K Strupat
Journal:  J Am Soc Mass Spectrom       Date:  1999-11       Impact factor: 3.109

6.  Myeloid related protein 8 and 14 secretion reflects phagocyte activation and correlates with disease activity in juvenile idiopathic arthritis treated with autologous stem cell transplantation.

Authors:  N M Wulffraat; P J Haas; M Frosch; I M De Kleer; T Vogl; D M C Brinkman; P Quartier; J Roth; W Kuis
Journal:  Ann Rheum Dis       Date:  2003-03       Impact factor: 19.103

Review 7.  Pursuing Multiple Biomarkers for Early Idiopathic Parkinson's Disease Diagnosis.

Authors:  Yareth Gopar-Cuevas; Ana P Duarte-Jurado; Rosa N Diaz-Perez; Odila Saucedo-Cardenas; Maria J Loera-Arias; Roberto Montes-de-Oca-Luna; Humberto Rodriguez-Rocha; Aracely Garcia-Garcia
Journal:  Mol Neurobiol       Date:  2021-08-05       Impact factor: 5.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.